Accelerating the Development of Biomarkers for Drug Safety Workshop Summary (2009) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 65-70
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 65... ...
Duke University Medical Center
|
From page 66... ...
Food and Drug Administration daNiel blooMfield Merck Research Laboratories Hepatotoxicity 8:45–9:00 Paul WatkiNs university of North Carolina at Chapel Hill Nephrotoxicity 9:00–9:15 fRaNk sistaRe Merck Research Laboratories Panel Discussion 9:15–10:10 10:10–10:15 Charge to the breakout Groups RobeRt Califf (Forum Member) Duke University Medical Center 10:15–10:30 bREAk
|
From page 67... ...
Food and Drug Administration
|
From page 68... ...
Duke University Medical Center Nephrotoxicity breakout Report 1:45–2:00 PRasad devaRajaN C incinnati Children's Hospital Medical Center, University of Cincinnati Hepatotoxicity breakout Report 2:00–2:15 johN blooM Eli Lilly and Company
|
From page 69... ...
Moderator: RobeRt Califf (Forum Member) Duke University Medical Center Regulatory Considerations for validation and Qualification 3:30–3:45 of Multimarker Panels jaNet WoodCoCk (Forum Member)
|
From page 70... ...
• How could these efforts be advanced through public or private means?
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.